The health system is facing economic stress, a well-known fact that is largely attributed to the aging population leading to an increase in demand for healthcare services. However, the underlying issue also lies in the constant innovation in healthcare that is allowing individuals to age better, but at a cost. The question arises – is this innovation an expense or an investment in the sustainability of the health system?
The Roche Institute has recently released a report titled “The value of Personalized Precision Medicine in the sustainability and efficiency of the health system,” which delves into this very question. Maria Isidoro, an expert collaborator of the study, highlights how Precision Medicine can improve the efficiency of the health system by reducing costs and time, identifying susceptible populations, anticipating disease development, using biomarkers for prognosis, and minimizing side effects through targeted treatments.
Enrique de Álava, another coordinator of the report, stresses the need to evaluate the economic results of actions taken in healthcare and communicate them effectively to managers and administrators. He emphasizes the importance of measuring not only costs but also health outcomes, calling for a National Commission for Precision Medicine to coordinate regional efforts and create multidisciplinary teams to address these challenges.
In conclusion, the objective is for everyone involved in the healthcare sector to learn from each other and work towards a more sustainable and efficient health system that benefits individuals at every level.